BARCLAYS PLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$43,268,000
-59.9%
1,861,789
-72.6%
0.04%
-54.9%
Q1 2018$108,018,000
-43.8%
6,785,064
-26.7%
0.08%
-47.8%
Q4 2017$192,255,000
+105.3%
9,251,878
+41.6%
0.16%
+63.5%
Q3 2017$93,654,000
+45.2%
6,535,515
+75.3%
0.10%
+39.1%
Q2 2017$64,503,000
+48.6%
3,728,471
-5.3%
0.07%
+43.8%
Q1 2017$43,419,000
-74.8%
3,936,497
-66.8%
0.05%
-74.3%
Q4 2016$172,193,000
-29.4%
11,859,013
+19.3%
0.19%
-31.2%
Q3 2016$244,057,000
-10.4%
9,941,282
-26.5%
0.27%
-23.2%
Q2 2016$272,408,000
-15.2%
13,525,673
+9.4%
0.35%
-27.8%
Q1 2016$321,341,000
-69.4%
12,359,306
+19.0%
0.49%
-61.5%
Q4 2015$1,048,636,000
-28.6%
10,382,544
+25.8%
1.27%
-28.1%
Q3 2015$1,469,106,000
-28.5%
8,253,400
-10.8%
1.77%
-23.2%
Q2 2015$2,053,376,000
-27.2%
9,249,437
-35.0%
2.30%
-29.1%
Q1 2015$2,819,474,000
+31.3%
14,239,777
-5.2%
3.25%
+57.3%
Q4 2014$2,146,867,000
+44.1%
15,013,047
+32.0%
2.07%
+44.3%
Q3 2014$1,489,446,000
+14.8%
11,369,803
+10.4%
1.43%
+4.3%
Q2 2014$1,297,733,000
+13.2%
10,299,460
+17.7%
1.37%
+5.7%
Q1 2014$1,146,585,000
+40.7%
8,752,546
+25.7%
1.30%
+55.4%
Q4 2013$814,858,000
+99.9%
6,964,612
+77.7%
0.84%
+72.0%
Q3 2013$407,571,000
+20.8%
3,918,951
+0.0%
0.49%
+15.7%
Q2 2013$337,290,0003,918,3310.42%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2014
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders